GlassScriptPhysician profile
Stephanie M Berg
NPI 1629047659
$14,595.94
in general payments reported to CMS, 2019-2025
60 companies · $1,331 in 2025
The $1,331 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,792 · 2020: $1,094 · 2021: $3,338 · 2022: $2,451 · 2023: $2,032 · 2024: $1,559 · 2025: $1,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,907 · Education: $15.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,906.68 |
| Education | $15.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,796.67 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Currax Pharmaceuticals LLC | $2,633.82 | 2019-2023 | Contrave |
| Abbvie INC. | $2,415.01 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Lilly USA, LLC | $669.07 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $517.62 | 2019-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $479.56 | 2019-2025 | Airsupra, Farxiga |
| Kvk-Tech, INC. | $469.63 | 2019-2021 | |
| Corcept Therapeutics | $335.24 | 2024-2025 | Korlym |
| Antares Pharma, INC. | $332.72 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $260.96 | 2019-2025 | |
| Amarin Pharma, INC. | $234.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.76 | 2022-2025 | Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $201.89 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $194.31 | 2019-2024 | Trintellix |
| Allergan, INC. | $184.70 | 2019-2020 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.